treatment in high-risk patients. The first urgent unmet needs that we are addressing are in the neonatal intensive care unit; where our clinically proven, and patented technologies will have the greatest impact. Through curation and analysis, their AI platform generates unique datasets which can be used by SIME to discover new products, or by third-party commercial partners in all areas of medicine.

SIME is a London (UK), Copenhagen (Denmark), and Shanghai (China) based company with over three decades of experience of pioneering innovation in medicine and data science.